$ACHC
Acadia Healthcare Company, Inc.

2012 Q4 Form 10-Q Financial Statement

#000119312512460463 Filed on November 08, 2012

View on sec.gov

Income Statement

Concept 2012 Q4 2012 Q3 2011 Q3
Revenue $114.3M $103.1M $60.72M
YoY Change 51.62% 69.82% 296.88%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $78.50M $71.20M $46.30M
YoY Change 44.83% 53.78% 313.39%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $2.700M $2.000M $900.0K
YoY Change 125.0% 122.22% 28.57%
% of Gross Profit
Operating Expenses $93.20M $92.81M $56.24M
YoY Change 48.41% 65.01% 329.34%
Operating Profit
YoY Change
Interest Expense -$7.600M $7.433M $1.928M
YoY Change 52.0% 285.53% -1064.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $7.506M $10.31M $4.479M
YoY Change -131.98% 130.21% 148.83%
Income Tax $3.000M $3.723M $908.0K
% Of Pretax Income 39.97% 36.11% 20.27%
Net Earnings $4.365M $6.450M $3.123M
YoY Change -127.44% 106.53% 95.19%
Net Earnings / Revenue 3.82% 6.26% 5.14%
Basic Earnings Per Share $0.15 $0.18
Diluted Earnings Per Share $100.7K $0.15 $0.18
COMMON SHARES
Basic Shares Outstanding 41.82M shares 41.76M shares 17.63M shares
Diluted Shares Outstanding 41.99M shares 17.63M shares

Balance Sheet

Concept 2012 Q4 2012 Q3 2011 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $49.40M $11.70M $1.300M
YoY Change -19.15% 800.0%
Cash & Equivalents $49.40M $11.72M $1.254M
Short-Term Investments
Other Short-Term Assets $16.33M $15.31M $9.600M
YoY Change 61.37% 59.43%
Inventory
Prepaid Expenses $3.507M
Receivables $63.87M $54.78M $25.50M
Other Receivables $4.630M $0.00 $0.00
Total Short-Term Assets $141.0M $87.03M $36.40M
YoY Change 25.2% 139.1%
LONG-TERM ASSETS
Property, Plant & Equipment $236.9M $155.2M $57.80M
YoY Change 185.57% 168.49%
Goodwill $557.4M $334.6M
YoY Change 198.37%
Intangibles $15.99M $12.53M
YoY Change 94.22%
Long-Term Investments
YoY Change
Other Assets $32.10M $14.38M $9.500M
YoY Change 96.14% 51.4%
Total Long-Term Assets $842.4M $516.7M $233.2M
YoY Change 180.45% 121.58%
TOTAL ASSETS
Total Short-Term Assets $141.0M $87.03M $36.40M
Total Long-Term Assets $842.4M $516.7M $233.2M
Total Assets $983.4M $603.8M $269.6M
YoY Change 138.12% 123.95%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $19.08M $13.32M $11.00M
YoY Change 120.79% 21.12%
Accrued Expenses $16.34M $13.37M $18.70M
YoY Change 79.95% -28.48%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $7.680M $12.00M $6.800M
YoY Change 13.78% 76.47%
Total Short-Term Liabilities $71.85M $57.82M $36.40M
YoY Change 76.68% 58.85%
LONG-TERM LIABILITIES
Long-Term Debt $465.6M $284.6M $131.4M
YoY Change 72.01% 116.61%
Other Long-Term Liabilities $12.38M $6.574M $24.80M
YoY Change 135.55% -73.49%
Total Long-Term Liabilities $478.0M $291.2M $156.2M
YoY Change 73.22% 86.43%
TOTAL LIABILITIES
Total Short-Term Liabilities $71.85M $57.82M $36.40M
Total Long-Term Liabilities $478.0M $291.2M $156.2M
Total Liabilities $550.9M $350.2M $192.6M
YoY Change 73.98% 81.83%
SHAREHOLDERS EQUITY
Retained Earnings -$24.18M -$28.54M
YoY Change -45.77%
Common Stock $499.0K $418.0K
YoY Change 55.45%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $432.6M $253.6M $77.00M
YoY Change
Total Liabilities & Shareholders Equity $983.4M $603.8M $269.6M
YoY Change 138.12% 123.95%

Cashflow Statement

Concept 2012 Q4 2012 Q3 2011 Q3
OPERATING ACTIVITIES
Net Income $4.365M $6.450M $3.123M
YoY Change -127.44% 106.53% 95.19%
Depreciation, Depletion And Amortization $2.700M $2.000M $900.0K
YoY Change 125.0% 122.22% 28.57%
Cash From Operating Activities $10.60M $12.80M $4.000M
YoY Change -137.46% 220.0% -27.27%
INVESTING ACTIVITIES
Capital Expenditures -$15.50M -$43.80M -$3.500M
YoY Change 64.89% 1151.43% 483.33%
Acquisitions
YoY Change
Other Investing Activities -$279.1M -$75.70M -$300.0K
YoY Change 882.75% 25133.33% -25.0%
Cash From Investing Activities -$294.6M -$119.4M -$3.900M
YoY Change 679.37% 2961.54% 290.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $172.8M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 321.7M -1.800M -2.300M
YoY Change 155.72% -21.74% -4.17%
NET CHANGE
Cash From Operating Activities 10.60M 12.80M 4.000M
Cash From Investing Activities -294.6M -119.4M -3.900M
Cash From Financing Activities 321.7M -1.800M -2.300M
Net Change In Cash 37.70M -108.4M -2.200M
YoY Change -36.85% 4827.27% -204.76%
FREE CASH FLOW
Cash From Operating Activities $10.60M $12.80M $4.000M
Capital Expenditures -$15.50M -$43.80M -$3.500M
Free Cash Flow $26.10M $56.60M $7.500M
YoY Change -238.1% 654.67% 22.95%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2011Q4 us-gaap Long Term Debt
LongTermDebt
150000000
CY2012Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
41816306 shares
CY2012Q2 us-gaap Common Stock Discount On Shares
CommonStockDiscountOnShares
6400000
CY2012Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9487500 shares
CY2012Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
15.50
CY2011Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1254000
CY2012Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
90000000 shares
CY2012Q3 us-gaap Other Assets Current
OtherAssetsCurrent
15305000
CY2012Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
253563000
CY2012Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
19125000
CY2012Q3 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
175900000
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
2700000 shares
CY2012Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2012Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3088000
CY2012Q3 us-gaap Liabilities Current
LiabilitiesCurrent
57822000
CY2012Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
300000
CY2012Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-28542000
CY2012Q3 us-gaap Assets
Assets
603758000
CY2012Q3 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
74600000
CY2012Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11719000
CY2012Q3 us-gaap Business Acquisition Purchase Price Allocation Intangible Assets Other Than Goodwill
BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsOtherThanGoodwill
3317000
CY2012Q3 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
75000000
CY2012Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
54777000
CY2012Q3 us-gaap Business Acquisition Purchase Price Allocation Current Liabilities Accounts Payable
BusinessAcquisitionPurchasePriceAllocationCurrentLiabilitiesAccountsPayable
1899000
CY2012Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
600000
CY2012Q3 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
10536000
CY2012Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
6581000
CY2012Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
165881000
CY2012Q3 us-gaap Business Acquisition Purchase Price Allocation Property Plant And Equipment
BusinessAcquisitionPurchasePriceAllocationPropertyPlantAndEquipment
590000
CY2012Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
14383000
CY2012Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
200000
CY2012Q3 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
1167000
CY2012Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
603758000
CY2012Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
41773053 shares
CY2012Q3 us-gaap Business Acquisition Purchase Price Allocation Assets Acquired
BusinessAcquisitionPurchasePriceAllocationAssetsAcquired
78968000
CY2012Q3 us-gaap Common Stock Value
CommonStockValue
418000
CY2012Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1090000
CY2012Q3 us-gaap Goodwill
Goodwill
334622000
CY2012Q3 us-gaap Business Acquisition Purchase Price Allocation Current Assets Prepaid Expense And Other Assets
BusinessAcquisitionPurchasePriceAllocationCurrentAssetsPrepaidExpenseAndOtherAssets
168000
CY2012Q3 us-gaap Business Acquisition Purchase Price Allocation Current Liabilities Accrued Liabilities
BusinessAcquisitionPurchasePriceAllocationCurrentLiabilitiesAccruedLiabilities
653000
CY2012Q3 us-gaap Business Acquisition Purchase Price Allocation Assets Acquired Liabilities Assumed Net
BusinessAcquisitionPurchasePriceAllocationAssetsAcquiredLiabilitiesAssumedNet
75515000
CY2012Q3 us-gaap Liabilities
Liabilities
350195000
CY2012Q3 us-gaap Long Term Debt
LongTermDebt
296632000
CY2012Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
12534000
CY2012Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
400000
CY2012Q3 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
5230000
CY2012Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2012Q3 us-gaap Business Acquisition Purchase Price Allocation Current Liabilities Other Liabilities
BusinessAcquisitionPurchasePriceAllocationCurrentLiabilitiesOtherLiabilities
901000
CY2012Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
13374000
CY2012Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2012Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2012Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
155188000
CY2012Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
12000000
CY2012Q3 us-gaap Business Acquisition Purchase Price Allocation Current Assets Receivables
BusinessAcquisitionPurchasePriceAllocationCurrentAssetsReceivables
2845000
CY2012Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
41773053 shares
CY2012Q3 us-gaap Business Acquisition Purchase Price Allocation Liabilities Assumed
BusinessAcquisitionPurchasePriceAllocationLiabilitiesAssumed
3453000
CY2012Q3 us-gaap Assets Current
AssetsCurrent
87031000
CY2012Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
281687000
CY2012Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
500000
CY2012Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
10693000
CY2012Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
284632000
CY2012Q3 us-gaap Stockholders Equity
StockholdersEquity
253563000
CY2012Q3 us-gaap Business Acquisition Purchase Price Allocation Goodwill Amount
BusinessAcquisitionPurchasePriceAllocationGoodwillAmount
72048000
CY2012Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
6574000
CY2012Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
13323000
CY2012Q3 achc Identifiable Intangible Assets Net Excluding Goodwill
IdentifiableIntangibleAssetsNetExcludingGoodwill
13624000
CY2012Q3 achc Line Of Credit Facility Initial Amount
LineOfCreditFacilityInitialAmount
30000000
CY2012Q3 achc Unrecognized Compensation Expense Related To Unvested Options And Unrestricted Stock
UnrecognizedCompensationExpenseRelatedToUnvestedOptionsAndUnrestrictedStock
6500000
CY2010Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8614000
CY2011Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
90000000 shares
CY2011Q4 us-gaap Other Assets Current
OtherAssetsCurrent
10121000
CY2011Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
96365000
CY2011Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
16195000
CY2011Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2011Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
2773000
CY2011Q4 us-gaap Liabilities Current
LiabilitiesCurrent
40668000
CY2011Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
6006000
CY2011Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-44580000
CY2011Q4 us-gaap Assets
Assets
412996000
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
61118000
CY2011Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
35127000
CY2011Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
6091000
CY2011Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2424000
CY2011Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
88796000
CY2011Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
16366000
CY2011Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
412996000
CY2011Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32115929 shares
CY2011Q4 us-gaap Common Stock Value
CommonStockValue
321000
CY2011Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
632000
CY2011Q4 us-gaap Goodwill
Goodwill
186815000
CY2011Q4 us-gaap Liabilities
Liabilities
316631000
CY2011Q4 us-gaap Long Term Debt
LongTermDebt
277459000
CY2011Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
8232000
CY2011Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
6239000
CY2011Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2011Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9081000
CY2011Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2011Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2011Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
82972000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17633000 shares
CY2011Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
6750000
CY2011Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
32115929 shares
CY2011Q4 us-gaap Assets Current
AssetsCurrent
112605000
CY2011Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
140624000
CY2011Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2011Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5824000
CY2011Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
270709000
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
96365000
CY2011Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5254000
CY2011Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
8642000
CY2011Q4 achc Identifiable Intangible Assets Net Excluding Goodwill
IdentifiableIntangibleAssetsNetExcludingGoodwill
8864000
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
6500000
us-gaap Health Care Organization Revenue
HealthCareOrganizationRevenue
141143000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3108000
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.03
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
178014000
us-gaap Payments Of Distributions To Affiliates
PaymentsOfDistributionsToAffiliates
375000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-187817000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
5907000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17633000 shares
us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
-213073000
us-gaap Repayments Of Debt
RepaymentsOfDebt
9984000
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.03
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4078000
us-gaap Share Based Compensation
ShareBasedCompensation
19843000
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
297172000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
8425000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1654000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
3108000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-7360000
us-gaap Payments To Acquire Real Estate
PaymentsToAcquireRealEstate
2150000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-187587000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
170000
us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
-230000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.08
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
12760000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-109000
us-gaap Net Income Loss
NetIncomeLoss
-18983000
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-18421000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.08
us-gaap Sponsor Fees
SponsorFees
1135000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
107000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
172888000
us-gaap Proceeds From Contributions From Parent
ProceedsFromContributionsFromParent
51029000
us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
3228000
us-gaap Operating Expenses
OperatingExpenses
156138000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3426000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
6208000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6777000
us-gaap Health Care Organization Medical Supplies And Drugs Expense
HealthCareOrganizationMedicalSuppliesAndDrugsExpense
7645000
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-1.05
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1400000
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-856000
us-gaap Professional Fees
ProfessionalFees
5018000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
646000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
19843000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-14995000
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
3576000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
108158000
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
217000
us-gaap Severance Costs
SeveranceCosts
1702000
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
3375000
us-gaap Liabilities Assumed1
LiabilitiesAssumed1
-35059000
us-gaap Interest Expense
InterestExpense
4143000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
618000
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
10595000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
7569000
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-1.05
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
684000
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-562000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
135000000
achc Advisory Fees Paid To Equity Sponsor
AdvisoryFeesPaidToEquitySponsor
3600000
achc Business Acquisitions Pro Forma Income Loss From Continuing Operations Before Income Taxes
BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeIncomeTaxes
-14406000
achc Health Care Organization Revenue Before Provision For Doubtful Accounts
HealthCareOrganizationRevenueBeforeProvisionForDoubtfulAccounts
142797000
achc Legal Accounting And Other Fees
LegalAccountingAndOtherFees
5293000
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2012
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2012-09-30
dei Entity Central Index Key
EntityCentralIndexKey
0001520697
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Trading Symbol
TradingSymbol
ACHC
dei Entity Registrant Name
EntityRegistrantName
Acadia Healthcare Company, Inc.
dei Amendment Flag
AmendmentFlag
false
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
us-gaap Health Care Organization Revenue
HealthCareOrganizationRevenue
293209000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-1029000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-230006000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
1197000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5332000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
515000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
165981000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
515000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
36795000 shares
us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
-172267000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.368 pure
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3M18D
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
19026000
us-gaap Share Based Compensation
ShareBasedCompensation
1691000
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
322599000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
23663000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
5429000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
5332000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-49399000
us-gaap Payments To Acquire Real Estate
PaymentsToAcquireRealEstate
50745000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-230006000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
9000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1691000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.44
us-gaap Nature Of Operations
NatureOfOperations
<div> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2"><b>1.</b></font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2"><b>Description of Business and Basis of Presentation</b></font></td> </tr> </table> <p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Description of Business</i></b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Acadia Healthcare Company, Inc. (hereinafter referred to as &#x201C;Acadia&#x201D; or the &#x201C;Company&#x201D;) develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities and facilities providing outpatient behavioral health services to better serve the behavioral health and recovery needs of communities throughout the United States. At September&#xA0;30, 2012, the Company operated 33 behavioral health facilities with over 2,300 beds in 19 states.</font></p> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Basis of Presentation</i></b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2"><font style="FONT-FAMILY: Times New Roman" size="2">The business of the Company is conducted through limited liability companies and C-corporations, each of which is a direct or indirect wholly-owned subsidiary of the Company. The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation.</font></font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2"><font style="FONT-FAMILY: Times New Roman" size="2">Prior to April&#xA0;1, 2011, the Company and its limited liability company subsidiaries were taxed as flow-through entities and as such, the results of operations of the Company related to the flow-through entities were included in the income tax returns of its members. On April&#xA0;1, 2011, the Company and its wholly-owned LLC subsidiaries elected to be taxed as a corporation for federal and state income tax purposes, and, therefore, income taxes became the obligation of the Company subsequent to April&#xA0;1, 2011.</font></font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The accompanying consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (&#x201C;GAAP&#x201D;) for interim financial information. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for fair presentation of our financial position and results of operations have been included. The Company&#x2019;s fiscal year ends on December&#xA0;31 and interim results are not necessarily indicative of results for a full year or any other interim period. The condensed consolidated balance sheet at December&#xA0;31, 2011 has been derived from the audited financial statements as of that date. The information contained in these condensed consolidated financial statements should be read in conjunction with the Company&#x2019;s consolidated financial statements and notes thereto for the fiscal year ended December&#xA0;31, 2011 included in the Company&#x2019;s Annual Report on Form 10-K filed with the Securities and Exchange Commission on March&#xA0;13, 2012. The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ from those estimates.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Certain reclassifications have been made to prior years to conform to the current year presentation.</font></p> </div>
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
30768000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
8138000
us-gaap Net Income Loss
NetIncomeLoss
16038000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.013 pure
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
16016000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.43
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
527000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37006000 shares
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
157272000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.42 pure
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
211000 shares
us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
3570000
us-gaap Severance Costs
SeveranceCosts
139000
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
6000000
us-gaap Liabilities Assumed1
LiabilitiesAssumed1
-6286000
us-gaap Goodwill Translation And Purchase Accounting Adjustments
GoodwillTranslationAndPurchaseAccountingAdjustments
1244000
us-gaap Operating Expenses
OperatingExpenses
267886000
us-gaap Line Of Credit Facility Increase Decrease For Period Net
LineOfCreditFacilityIncreaseDecreaseForPeriodNet
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9307000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
4817000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
138954000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
14511000
us-gaap Health Care Organization Medical Supplies And Drugs Expense
HealthCareOrganizationMedicalSuppliesAndDrugsExpense
14148000
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.43
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
500000
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-328000
us-gaap Professional Fees
ProfessionalFees
13521000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-1231000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1691000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
25323000
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
6244000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
173590000
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
1527000
us-gaap Interest Expense
InterestExpense
22186000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
6.81
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
138954000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
pure
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
3677000
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
2097000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
23335000
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.44
us-gaap Disposal Group Including Discontinued Operation Operating Income Loss
DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss
200000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1869000
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
22000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
25000000
achc Business Acquisitions Pro Forma Income Loss From Continuing Operations Before Income Taxes
BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeIncomeTaxes
28488000
achc Capitalized Cost Incurred
CapitalizedCostIncurred
400000
achc Health Care Organization Revenue Before Provision For Doubtful Accounts
HealthCareOrganizationRevenueBeforeProvisionForDoubtfulAccounts
298638000
achc Legal Accounting And Other Fees
LegalAccountingAndOtherFees
1958000
achc Share Based Compensation Arrangement By Share Based Payment Award
ShareBasedCompensationArrangementByShareBasedPaymentAward
0.25 pure
CY2011Q3 us-gaap Net Income Loss
NetIncomeLoss
3123000
CY2011Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.02
CY2011Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17633000 shares
CY2011Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.02
CY2011Q3 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
99068000
CY2011Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
663000
CY2011Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
909000
CY2011Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.18
CY2011Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
4915000
achc Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Vesting Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageVestingPeriod
P1Y7M21D
achc Share Based Compensation Arrangement By Share Based Payment Stock Options Granted Term
ShareBasedCompensationArrangementByShareBasedPaymentStockOptionsGrantedTerm
P10Y
achc Number Of Real Estate Properties Purchased
NumberOfRealEstatePropertiesPurchased
6 Lease
CY2012Q2 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
700000
CY2012Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
139000000
CY2011Q4 achc Number Of Acquired Bed Substance Abuse Facility Closed In Period
NumberOfAcquiredBedSubstanceAbuseFacilityClosedInPeriod
24 Beds
CY2011Q4 achc Number Of Outpatient Facilities Closed
NumberOfOutpatientFacilitiesClosed
3 Facility
CY2011 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3M18D
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.012 pure
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.42 pure
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.98
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
pure
CY2011 achc Capitalized Cost Incurred
CapitalizedCostIncurred
400000
CY2011Q3 us-gaap Health Care Organization Revenue
HealthCareOrganizationRevenue
60722000
CY2011Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
3571000
CY2011Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.18
CY2011Q3 us-gaap Sponsor Fees
SponsorFees
545000
CY2011Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17633000 shares
CY2011Q3 us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
1674000
CY2011Q3 us-gaap Operating Expenses
OperatingExpenses
56243000
CY2011Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
908000
CY2011Q3 us-gaap Health Care Organization Medical Supplies And Drugs Expense
HealthCareOrganizationMedicalSuppliesAndDrugsExpense
3398000
CY2011Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.20
CY2011Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
100000
CY2011Q3 us-gaap Professional Fees
ProfessionalFees
2302000
CY2011Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
0
CY2011Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4479000
CY2011Q3 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1591000
CY2011Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
38422000
CY2011Q3 us-gaap Severance Costs
SeveranceCosts
307000
CY2011Q3 us-gaap Interest Expense
InterestExpense
1928000
CY2011Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
2233000
CY2011Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.20
CY2011Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-448000
CY2011Q3 achc Business Acquisitions Pro Forma Income Loss From Continuing Operations Before Income Taxes
BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeIncomeTaxes
4179000
CY2011Q3 achc Health Care Organization Revenue Before Provision For Doubtful Accounts
HealthCareOrganizationRevenueBeforeProvisionForDoubtfulAccounts
61385000
CY2011Q3 achc Legal Accounting And Other Fees
LegalAccountingAndOtherFees
1926000
CY2012Q3 us-gaap Health Care Organization Revenue
HealthCareOrganizationRevenue
103116000
CY2012Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.01
CY2012Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
41757000 shares
CY2012Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.01
CY2012Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.361 pure
CY2012Q3 us-gaap Share Based Compensation
ShareBasedCompensation
500000
CY2012Q3 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
108984000
CY2012Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1502000
CY2012Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2076000
CY2012Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.15
CY2012Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
11380000
CY2012Q3 us-gaap Net Income Loss
NetIncomeLoss
6450000
CY2012Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
6588000
CY2012Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.15
CY2012Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
41991000 shares
CY2012Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
234000 shares
CY2012Q3 us-gaap Operating Expenses
OperatingExpenses
92805000
CY2012Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3723000
CY2012Q3 us-gaap Health Care Organization Medical Supplies And Drugs Expense
HealthCareOrganizationMedicalSuppliesAndDrugsExpense
4831000
CY2012Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.16
CY2012Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
100000
CY2012Q3 us-gaap Professional Fees
ProfessionalFees
4690000
CY2012Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
521000
CY2012Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
10311000
CY2012Q3 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1775000
CY2012Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
59888000
CY2012Q3 us-gaap Severance Costs
SeveranceCosts
103000
CY2012Q3 us-gaap Interest Expense
InterestExpense
7433000
CY2012Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
732000
CY2012Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.16
CY2012Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-138000
CY2012Q3 achc Business Acquisitions Pro Forma Income Loss From Continuing Operations Before Income Taxes
BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeIncomeTaxes
10777000
CY2012Q3 achc Health Care Organization Revenue Before Provision For Doubtful Accounts
HealthCareOrganizationRevenueBeforeProvisionForDoubtfulAccounts
104618000
CY2012Q3 achc Legal Accounting And Other Fees
LegalAccountingAndOtherFees
629000

Files In Submission

Name View Source Status
0001193125-12-460463-index-headers.html Edgar Link pending
0001193125-12-460463-index.html Edgar Link pending
0001193125-12-460463.txt Edgar Link pending
0001193125-12-460463-xbrl.zip Edgar Link pending
achc-20120930.xml Edgar Link completed
achc-20120930.xsd Edgar Link pending
achc-20120930_cal.xml Edgar Link unprocessable
achc-20120930_def.xml Edgar Link unprocessable
achc-20120930_lab.xml Edgar Link unprocessable
achc-20120930_pre.xml Edgar Link unprocessable
d414998d10q.htm Edgar Link pending
d414998dex311.htm Edgar Link pending
d414998dex312.htm Edgar Link pending
d414998dex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending